Biotime Pharmaceuticals Private Limited, a active private limited company, was established on 15 September 2016 in Ambernath, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24110MH2016PTC285926. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.
It upholds a compliant status. Its leadership includes Lachmandas Gelaram Lund (Director), Nitesh Lachman Lund (Director), Kiran Lachmandas Lund (Director). It holds ₹5.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 29, Shop No. 2, Shivaji Chawk, Shiv Mandir,, Ambernath, Maharashtra, 421501.
U24110MH2016PTC285926
285926
15 September 2016
₹2.00 Cr
₹2.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Biotime Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lachmandas Gelaram Lund | Director | 15 Sep 2016 | Current |
| Nitesh Lachman Lund | Director | 15 Sep 2016 | Current |
| Kiran Lachmandas Lund | Director | 15 Sep 2016 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Biotime Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 251.46% decrease in profit. The company's net worth observed a substantial decline by a decrease of 67.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Biotime Pharmaceuticals had a public holding of 7.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2021 | Others | ₹5.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Biotime Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Biotime Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotime Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Biotime Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Biotime Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100456504 was registered on 28 Jun 2021. was recorded as a recent event.
Lachmandas Gelaram Lund was appointed as a Director was appointed as a Director on 15 Sep 2016 & has been associated with this company since 9 years 3 months . was recorded as a recent event.
The activity Nitesh Lachman Lund was appointed as a Director was appointed as a Director on 15 Sep 2016 & has been associated with this company since 9 years 3 months . was completed.
Progress on Kiran Lachmandas Lund was appointed as a Director was appointed as a Director on 15 Sep 2016 & has been associated with this company since 9 years 3 months . was documented.
The CIN of Biotime Pharmaceuticals Private Limited is U24110MH2016PTC285926.
Biotime Pharmaceuticals Private Limited is headquartered at Plot No. 29, Shop No. 2, Shivaji Chawk, Shiv Mandir,, Ambernath, Maharashtra, 421501.
Biotime Pharmaceuticals Private Limited was incorporated on 15 September 2016.
The current directors of Biotime Pharmaceuticals Private Limited are
The primary industry of Biotime Pharmaceuticals Private Limited is Pharma.
Biotime Pharmaceuticals Private Limited is unlisted.
The authorized capital of Biotime Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.
The compliance status of Biotime Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX